Healthcare/Biotech
|
Updated on 31 Oct 2025, 06:50 am
Reviewed By
Aditi Singh | Whalesbook News Team
▶
An international research team, led by Andreas Hougaard Laustsen-Kiel from DTU Bioengineering in Denmark, has developed a potential game-changer for snakebite envenoming, a neglected tropical disease causing significant global mortality and morbidity. This new anti-venom utilizes antibody fragments called 'nanobodies,' offering advantages over traditional methods which use larger antibodies from animals like horses. Nanobodies are smaller, penetrate tissues faster and deeper, and carry a lower risk of severe immune reactions. A major limitation of current anti-venoms is their specificity to only a few snake species. The new research combines eight nanobodies into a cocktail effective against venom from 18 medically relevant African snake species. Preclinical tests showed it neutralized venom from 17 out of 18 species.
Impact: This breakthrough could significantly reduce snakebite-related deaths, disabilities, and amputations worldwide, particularly in affected tropical regions. It offers hope for more effective and safer treatment options. Rating: 9/10
Difficult Terms: * Nanobodies: Antibody fragments, much smaller than conventional antibodies, used in the new anti-venom for better tissue penetration and reduced side effects. * Snakebite Envenoming: A disease caused by the injection of venom from a venomous snake. * Neglected Tropical Disease (NTD): Infectious diseases affecting poor populations in tropical/subtropical regions. * Antibodies: Proteins produced by the immune system to fight infections. * Neurotoxins: Poisons that attack the nervous system, causing paralysis. * Cytotoxins: Poisons that damage cells and tissues. * In vivo testing: Experiments conducted within a living organism.
Auto
Suzuki and Honda aren’t sure India is ready for small EVs. Here’s why.
Brokerage Reports
Stocks to buy: Raja Venkatraman's top picks for 4 November
Mutual Funds
Quantum Mutual Fund stages a comeback with a new CEO and revamped strategies; eyes sustainable growth
Tech
Why Pine Labs’ head believes Ebitda is a better measure of the company’s value
Banking/Finance
SEBI is forcing a nifty bank shake-up: Are PNB and BoB the new ‘must-owns’?
Industrial Goods/Services
India’s Warren Buffett just made 2 rare moves: What he’s buying (and selling)
Renewables
Brookfield lines up $12 bn for green energy in Andhra as it eyes $100 bn India expansion by 2030
Energy
India's green power pipeline had become clogged. A mega clean-up is on cards.